Memphasys Ltd has released a press release.
Felix Clinical Trial Reaches 95% Completion
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Memphasys
- RoXsta System Secures Provisional Patent Approval
- Completion of Placement and SPP offer
- MEM Investor Presentation
- Felix Trial registration update
- Equine study commences with 12mth commercialisation expected
Later from Memphasys
- RoXsta System's Potential in Cattle Breeding being Explored
- Order for Felix System to Evaluate Suitability in UAE
- Letter of Intent with Heranova for Felix System Distribution
- Felix Clinical Registration Study completed, expanding mkt
- Bovine Study commences to assess RoXsta antioxidant system
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys